KYMR stock rocketed and then toppled Friday after Kymera outlined its newest immune disease drugs and tacked on a $275 million offering.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Kymera Therapeutics Stock Whiplash: Shares Soar, Then Tumble After $275 Million Offering